NASDAQ:ADTX

Aditx Therapeutics Stock News

etoro logo Buy ADTX
*Your capital is at risk
$0.0417
+0.0225 (+117.19%)
At Close: Jun 23, 2026
MOUNTAIN VIEW, Calif. & GOLDEN, Colo. & HONG KONG--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”), a qualified acquisition corp and Ignite Proteomics, LLC (“Ignite”, or “Ignite Prot
GOLDEN, Colo.--(BUSINESS WIRE)--Ignite Proteomics, LLC (“Ignite” or “Ignite Proteomics”) a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), today announced the launch of a prospective oncology regis
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX)(“Aditxt” or the “Company”), a life sciences platform company accelerating promising health innovations, today announced the
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, announced today that it
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced that it
Aditxt, Inc. (NASDAQ: ADTX - Get Free Report) saw a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 44,231 shares, a decline of 38.3% f
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the app
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, today announced the acq
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, announced today that it
Ernexa Therapeutics (NASDAQ: ERNA - Get Free Report) and Aditxt (NASDAQ: ADTX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two compa
Aditxt, Inc. (NASDAQ: ADTX - Get Free Report) saw a significant decline in short interest in February. As of February 13th, there was short interest totaling 40,608 shares, a decline of 18.8% from the
Aditxt, Inc. (NASDAQ: ADTX - Get Free Report) saw a large decrease in short interest in January. As of January 30th, there was short interest totaling 49,980 shares, a decrease of 53.4% from the Janua
Aditxt (NASDAQ: ADTX - Get Free Report) and Avalo Therapeutics (NASDAQ: AVTX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two compa
Aditxt, Inc. (NASDAQ: ADTX - Get Free Report) was the target of a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 86,655 shares, a decl
U.S. stock futures rose on Wednesday after Tuesday's mixed close. Futures of major benchmark indices advanced.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE